These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3675599

  • 21. Development of tolerance to the prolongation of hexobarbitone sleeping time caused by cannabidiol.
    Borys HK, Ingall GB, Karler R.
    Br J Pharmacol; 1979 Sep; 67(1):93-101. PubMed ID: 497524
    [Abstract] [Full Text] [Related]

  • 22. The mechanism of the suicidal, reductive inactivation of microsomal cytochrome P-450 by carbon tetrachloride.
    Manno M, De Matteis F, King LJ.
    Biochem Pharmacol; 1988 May 15; 37(10):1981-90. PubMed ID: 3377806
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Cannabidiol is a potent inhibitor of the catalytic activity of cytochrome P450 2C19.
    Jiang R, Yamaori S, Okamoto Y, Yamamoto I, Watanabe K.
    Drug Metab Pharmacokinet; 2013 May 15; 28(4):332-8. PubMed ID: 23318708
    [Abstract] [Full Text] [Related]

  • 25. Characterization of cytochrome P450 3A inactivation by cannabidiol: possible involvement of cannabidiol-hydroxyquinone as a P450 inactivator.
    Bornheim LM, Grillo MP.
    Chem Res Toxicol; 1998 Oct 15; 11(10):1209-16. PubMed ID: 9778318
    [Abstract] [Full Text] [Related]

  • 26. The effects of delta9-tetrahydrocannabinol and cannabidiol on the metabolism of gonadal steroids in the rat.
    List A, Nazar B, Nyquist S, Harclerode J.
    Drug Metab Dispos; 1977 Oct 15; 5(3):268-72. PubMed ID: 17525
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Decarbonylation: A metabolic pathway of cannabidiol in humans.
    Kraemer M, Broecker S, Madea B, Hess C.
    Drug Test Anal; 2019 Jul 15; 11(7):957-967. PubMed ID: 30698361
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In vivo and in vitro metabolism of cannabidiol monomethyl ether and cannabidiol dimethyl ether in the guinea pig: on the formation mechanism of cannabielsoin-type metabolite from cannabidiol.
    Gohda H, Narimatsu S, Yamamoto I, Yoshimura H.
    Chem Pharm Bull (Tokyo); 1990 Jun 15; 38(6):1697-701. PubMed ID: 2208386
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome P-450IIC subfamily.
    Bornheim LM, Correia MA.
    Mol Pharmacol; 1991 Aug 15; 40(2):228-34. PubMed ID: 1875910
    [Abstract] [Full Text] [Related]

  • 36. Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes.
    Sawahata T, Neal RA.
    Mol Pharmacol; 1983 Mar 15; 23(2):453-60. PubMed ID: 6835203
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Drug metabolism in adult rat hepatocytes in primary monolayer culture.
    Guzelian PS, Bissell DM, Meyer UA.
    Gastroenterology; 1977 Jun 15; 72(6):1232-9. PubMed ID: 404208
    [Abstract] [Full Text] [Related]

  • 39. [Sex difference in the effects of delta 9-tetrahydrocannabinol and cannabidiol on pentobarbital-induced sleeping time and hepatic microsomal drug metabolizing enzyme systems in mice].
    Hamajima K, Watanabe K, Narimatsu S, Tateoka Y, Yamamoto I, Yoshimura H.
    Yakugaku Zasshi; 1983 Dec 15; 103(12):1289-97. PubMed ID: 6330340
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.